The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs.
D000342:Affective Symptoms / Q000188:drug therapy; D000928:Antidepressive Agents / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy / Q000378:metabolism*; D002395:Catecholamines / Q000378:metabolism*; D002396:Catechols / Q000652:urine; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000652:urine; D004569:Electroencephalography; D004837:Epinephrine / Q000652:urine; D006018:Glycols / Q000652:urine; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D009638:Norepinephrine / Q000652:urine; D012890:Sleep; D012895:Sleep, REM; D014364:Tryptophan / Q000627:therapeutic use
D000928:Antidepressive Agents; D002395:Catecholamines; D002396:Catechols; D006018:Glycols; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D014364:Tryptophan; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine